We partner with biopharma companies to discover novel treatments using the Benevolent Platform™. Our expertise spans across the entire drug discovery and development process and we can work on any therapeutic area or drug modality. Work with us ...
Uses AI to: Predict drug candidates by leveraging a convolutional neural network trained on a huge amount of organic chemistry data. Allows researchers to: Generate novel drug candidates faster (with a number of candidates already in development with partners). Founded: 2012. Headquarters: San ...
AI drug development optimization Why Owkin? Engaged with regulators Continued conversations with EMA and FDA including an EMA letter of support for our data-driven covariate adjustment approach and a CE-marked AI diagnostic tool: MSIntuit CRC. Robust, up-to-date, multimodal external data Access to...
Rapidly design structured nucleic acid drug candidates. 15K 250K 10 M 2 billion Unlimited Up to 1060compounds with binding for each target Achieve computer aided drug design Connect with us to learn how you can partner with Dianox. Select subjectOrder aptamersCo-developmentLicensingCareersOther ...
AI helps new drug development break the game, and listed companies grab the golden trackBreakings · Apr 11, 2024 06:58 Emerging technologies, led by large artificial intelligence (AI) models, are rapidly reshaping the pharmaceutical manufacturing industry. The integration of AI and the ...
The reviewed drug candidates of your interest from direct source will bring you to a deal. Join Bioneex Unlock the Power of Bioneex The platform facilitates biopharma partnerships and investment deals by connecting innovative drug development companies with the right partners and investors at the righ...
Drug discovery Pharma companies using AI are assisting in the research phase of drug development by analysing existing materials, publications, data and insights. Drug sales Using AI in the analysis of vast amounts of clinical data and returning actionable insights, reducing time spent on...
dollars had been invested by 11 out of the world's leading 20 'AI-first' biotech companies in the field of small molecules. 'AI-first' companies are biotech companies for which artificial intelligence/machine learning is the core of their discovery activities. ...
AI drug development optimization Why Owkin? Engaged with regulators Continued conversations with EMA and FDA including an EMA letter of support for our data-driven covariate adjustment approach and a CE-marked AI diagnostic tool: MSIntuit CRC. ...
The reviewed drug candidates of your interest from direct source will bring you to a deal. Join Bioneex Unlock the Power of Bioneex The platform facilitates biopharma partnerships and investment deals by connecting innovative drug development companies with the right partners and investors at the righ...